NewAmsterdam Pharma (NAMS) Interest & Investment Income (2023 - 2026)
NewAmsterdam Pharma's Interest & Investment Income was $5.81 million in Q2 2026, down 17.6% from $7.06 million a year earlier but up 2.8% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, NewAmsterdam Pharma's Interest & Investment Income was $24.65 million through Jun 30, 2026, up 5.6% year-over-year; for FY2025, it came in at $27.59 million, up 63.5% from FY2024.
- Interest & Investment Income shows a four-year compound annual growth rate of 613.4% (FY2021 to FY2025).
- In earlier years, Interest & Investment Income was $16.88 million in FY2024 (+49.6%), $11.28 million in FY2023, $11,594 in FY2022 (+8.9%) and $10,651 in FY2021.
- Quarterly Interest & Investment Income has moved between $943,000 (Q1 2023) and $7.35 million (Q1 2025) over five years.
- Compared with a year earlier, Interest & Investment Income was higher in six of the last eight quarters, with growth averaging 43.9%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q1 2024 (growth of 226.9%); the worst was Q1 2026 (a decline of 23.1%).
- Per Business Quant data, NAMS's Interest & Investment Income in the three quarters before Q2 2026 was $5.65 million (Q1 2026), $6.47 million (Q4 2025) and $6.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | NewAmsterdam Pharma | 2.73 Bn | 2.73 Bn | - | 5.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.81 Mn |
| Mar 31, 2026 | 5.65 Mn |
| Dec 31, 2025 | 6.47 Mn |
| Sep 30, 2025 | 6.71 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 7.35 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.87 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 4.61 Mn |
| Mar 31, 2023 | 943,000.00 |
API Access
NewAmsterdam Pharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();